Evaluation of Early Dexmedetomidine Addition to the Standard of Care for Severe Alcohol Withdrawal in the ICU: A Retrospective Controlled Cohort Study

Conclusions: This study suggests DEX is associated with a reduction in BZD requirement when utilized as adjunctive therapy for AWS. A larger prospective trial is needed to evaluate the clinical impact of DEX for AWS.

http://jic.sagepub.com/cgi/content/abstract/31/3/198?rss=1

Source: Journal of Intensive Care Medicine - January 26, 2016 Category: Intensive Care Authors: VanderWeide, L. A., Foster, C. J., MacLaren, R., Kiser, T. H., Fish, D. N., Mueller, S. W. Tags: Original Research Source Type: research

More News: Alcoholism | Intensive Care | Study